Equities research analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Tuesday. The ...
To read more about the latest highlights related to the PDC market, get a snapshot of the key highlights entailed in the ...
Detailed price information for Preveceutical Medical Inc (PRVCF) from The Globe and Mail including charting and trades.
StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a research report report ...
PALO ALTO, Calif. - The U.S. Bankruptcy Court for the Southern District of Texas has approved an extension of the lock-up period for Scilex Holding Company's (NASDAQ: SCLX) Dividend Stock to April 14, ...
Holdingannounced that the U.S. Bankruptcy Court for the Southern District of Texas has extended the expiration of the ...
CAMBRIDGE, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced the addition of Jerome ...
He also brings experience as an executive or board member at NexImmune, Sorrento Therapeutics, Sandoz Research Institute, Janssen Research Institute, PTC Therapeutics, Soligenix, and NexGel.
The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...
Shares of Summit Therapeutics (NASDAQ: SMMT) had jumped 14.3% at 11:31 a.m. ET on Tuesday. The nice gain came after reports that H.C. Wainwright analyst Mitchell Kapoor maintained a "buy" rating ...
The upstart, clinical stage biotech company Viking Therapeutics, Inc. (NASDAQ:VKTX), which is attempting to disrupt their market leadership has also suffered from a protracted hangover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results